Question 1

What specific symptoms of ADHD could this treatment help with?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

Question 2

How does MTS compare to other ADHD treatments we have tried?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of using MTS?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

Question 4

How long would my child need to participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or commitments I should be aware of if we participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD clinical trial (NCT00466791). Contact the study team or your healthcare provider for specific answers.

What this study is about